 |
| Editorials |  Top |
|
 |
 |
Focus on Diagnostics
Lost in validation p869
doi:10.1038/nbt0806-869
Abstract | Full text | PDF
(82K)
|
|
|
|
Focus on Diagnostics
Not for the chicken-hearted p870
doi:10.1038/nbt0806-870
Abstract | Full text | PDF
(60K)
|
|
| News | Top |
|
 |
|
| Data Page |
|
|
|
Focus on Diagnostics
Diagnostics investors think positive p884
Stacy Lawrence
doi:10.1038/nbt0806-884
Full text | PDF
(136K)
|
|
 |
|
| News Feature |
|
|
|
Focus on Diagnostics
Looking for solid ground along the Critical Path pp885 - 887
Mark Ratner
Published online: 03 August 2006 | doi:10.1038/nbt0806-885
Abstract | Full text | PDF
(470K)
|
|
|
|
Focus on Diagnostics
Genetic profiteering pp888 - 890
Laura De Francesco
Published online: 03 August 2006 | doi:10.1038/nbt0806-888
Abstract | Full text | PDF
(964K)
| Supplementary Information |
|
|
|
Focus on Diagnostics
Moving diagnostics from the bench to the bedside pp891 - 893
Jim Kling
Published online: 03 August 2006 | doi:10.1038/nbt0806-891
Abstract | Full text | PDF
(374K)
|
|
| Opinion and Comment | Top |
|
|
|
| Commentary |
|
|
|
Focus on Diagnostics
Cancer biomarkers: a systems approach pp905 - 908
Lee Hartwell, David Mankoff, Amanda Paulovich, Scott Ramsey & Elizabeth Swisher
doi:10.1038/nbt0806-905
Abstract | Full text | PDF
(141K)
|
|
|
|
Focus on Diagnostics
Translating in vivo diagnostics into clinical reality pp909 - 913
John V Frangioni
doi:10.1038/nbt0806-909
Abstract | Full text | PDF
(1,488K)
|
|
|
|
Focus on Diagnostics
What brown cannot do for you pp914 - 916
David L Rimm
doi:10.1038/nbt0806-914
Abstract | Full text | PDF
(444K)
|
|
|
|
Focus on Diagnostics
Three barriers to innovative diagnostics pp917 - 918
Paul R Billings
doi:10.1038/nbt0806-917
Abstract | Full text | PDF
(923K)
|
|
|
|
Focus on Diagnostics
Partnering for better microbial diagnostics pp919 - 921
Mark D Perkins & Peter M Small
doi:10.1038/nbt0806-919
Abstract | Full text | PDF
(295K)
|
|
|
|
Focus on Diagnostics
A change in the market—investing in diagnostics pp922 - 926
Keith Batchelder & Peter Miller
doi:10.1038/nbt0806-922
Abstract | Full text | PDF
(342K)
|
|
|
|
Focus on Diagnostics
A regulatory perspective on in vitro diagnostics pp927 - 929
Scott Gottlieb & Janet Woodcock
doi:10.1038/nbt0806-927
Abstract | Full text | PDF
(678K)
|
|
|
|
| Investor's Lab |
|
|
|
Focus on Diagnostics
Any diamonds in the diagnostic coal? p930
Tom Jacobs
doi:10.1038/nbt0806-930
Full text | PDF
(69K)
|
|
| Features | Top |
|
|
|
Focus on Diagnostics
New-wave diagnostics pp931 - 938
Monya Baker
doi:10.1038/nbt0806-931
Abstract | Full text | PDF
(2,215K)
|
|
|
|
| Patents |
|
|
|
Focus on Diagnostics
Emerging patent issues in genomic diagnostics pp939 - 941
John H Barton
doi:10.1038/nbt0806-939
Abstract | Full text | PDF
(596K)
|
|
|
|
Focus on Diagnostics
Shifting emphasis from pharmacogenomics to theragnostics pp942 - 946
Vural Ozdemir, Bryn Williams-Jones, Stephen J Glatt, Ming T Tsuang, James B Lohr & Christopher Reist
doi:10.1038/nbt0806-942
Abstract | Full text | PDF
(133K)
|
|
|
|
Focus on Diagnostics
Recent patent applications in molecular diagnostics p947
doi:10.1038/nbt0806-947
Full text | PDF
(41K)
|
|
| Research | Top |
|
|
|
| Perspective |
|
|
|
Focus on Diagnostics
Protein biomarker discovery and validation: the long and uncertain path to clinical utility pp971 - 983
Nader Rifai, Michael A Gillette & Steven A Carr
Published online: 09 August 2006 | doi:10.1038/nbt1235
Abstract | Full text | PDF
(384K)
|
|
|
|
| Review |
|
|
|
Focus on Diagnostics
The role of companion diagnostics in the development and use of mutation-targeted cancer therapies pp985 - 995
Nickolas Papadopoulos, Kenneth W Kinzler & Bert Vogelstein
Published online: 09 August 2006 | doi:10.1038/nbt1234
Abstract | Full text | PDF
(1,341K)
|
|
Top |
|
|
